APPLIED SPECTRAL IMAGING Ltd.

Applied Spectral Imaging (ASI) is a global leader in digital pathology and cytogenetics solutions with a three-decade legacy in biomedical imaging. The company develops computer-aided diagnostic software and imaging systems for brightfield, fluorescence, and spectral microscopy analysis. ASI serves clinical pathology and cytogenetic laboratories across 80+ countries through a network of distribution partners, including major academic medical centers (Cleveland Clinic, Duke, Montefiore). Core product lines include digital cytogenetics platforms for aided karyotyping and FISH (fluorescence in situ hybridization) scanning and analysis, and digital pathology solutions for H&E and immunohistochemistry (IHC) imaging with scanner-agnostic capabilities. Key software offerings include HiPath Pro for PD-L1 immunostaining interpretation and analysis, and metaphase finder/slide loader automation systems for increasing laboratory throughput and diagnostic accuracy. The company emphasizes integration of brightfield and fluorescence imaging modalities, tissue specimen matching, and user-centric design. ASI's solutions target improved inter- and intra-observer consistency, technologist productivity, and diagnostic confidence in cytogenetic and pathology workflows.